Livforsakringsbolaget Skandia Omsesidigt lessened its stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 0.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 17,199 shares of the company’s stock after selling 100 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in HCA Healthcare were worth $5,162,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of the company. Terra Nova Asset Management LLC increased its stake in HCA Healthcare by 0.3% during the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after purchasing an additional 26 shares during the period. Waldron Private Wealth LLC grew its position in HCA Healthcare by 1.8% in the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock valued at $683,000 after buying an additional 29 shares during the last quarter. Brookstone Capital Management raised its stake in shares of HCA Healthcare by 0.7% during the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock worth $1,652,000 after buying an additional 30 shares during the last quarter. UMB Bank n.a. raised its stake in HCA Healthcare by 2.4% in the 3rd quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock valued at $529,000 after purchasing an additional 30 shares during the last quarter. Finally, Integrated Advisors Network LLC raised its stake in HCA Healthcare by 0.6% in the 3rd quarter. Integrated Advisors Network LLC now owns 5,132 shares of the company’s stock valued at $2,086,000 after purchasing an additional 31 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.
Insider Buying and Selling
In related news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares of the company’s stock, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by insiders.
HCA Healthcare Stock Performance
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the company posted $5.90 EPS. As a group, analysts expect that HCA Healthcare, Inc. will post 24.89 earnings per share for the current year.
HCA Healthcare Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.89%. HCA Healthcare’s payout ratio is currently 12.02%.
Wall Street Analysts Forecast Growth
Several research firms have commented on HCA. Royal Bank of Canada lowered their price target on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday, January 27th. Wells Fargo & Company cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their target price for the stock from $400.00 to $320.00 in a report on Monday, November 25th. Cantor Fitzgerald restated an “overweight” rating and issued a $405.00 price target on shares of HCA Healthcare in a report on Monday, January 27th. Truist Financial cut their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Finally, Raymond James lowered HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $385.67.
Get Our Latest Stock Report on HCA Healthcare
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Stories
- Five stocks we like better than HCA Healthcare
- There Are Different Types of Stock To Invest In
- These are the 3 Stocks Most Likely to Split in 2025
- Canada Bond Market Holiday: How to Invest and Trade
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- 3 Healthcare Dividend Stocks to Buy
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.